Home > Press Releases > Pet Vaccines Market

Pet Vaccines Market Likely to Surpass USD 19.1 Billion by 2035

Report Code: HC-77687  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 303
Get PDF
Buy

Global Pet Vaccines Market Forecast 2035:

According to the report, the global pet vaccines market is projected to expand from USD 8.3 billion in 2025 to USD 19.1 billion by 2035, registering a CAGR of 8.7%, the highest during the forecast period. The pet vaccines market worldwide is experiencing a booming growth owing to the rising number of pet owners taking care of their pets by ensuring they are provided with preventive healthcare and the rising level of humanization of the pets. Pets are being considered more and more as part of the family, so many owners pay attention to the routine vaccination of their pets in order to prevent the infections and zoonotic diseases. It is also increasing the interest in animal health, leading to the demand of both core and non-core vaccines, such as rabies, distemper, parvovirus, leptospirosis, and respiratory infections.

The recent improvements in the technology of vaccines including recombinant, vector-based, and DNA vaccines are improving efficacy, safety, and convenience further stimulating market growth. Combination and multi-pathogen vaccines are becoming more popular due to their cost-effectiveness and convenience to administer, which pushes more people towards following the recommended immunization regimes.

The market also benefits from the increasing prevalence of pet insurance and wellness programs that promote preventive care, as well as the growing availability of digital tools and telehealth solutions that improve vaccination tracking and outreach. The global pet vaccinations market is experiencing continuous growth and increased dynamism due to ongoing innovation, improved distribution channels, and heightened awareness among veterinarians.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Pet Vaccines Market”

The pet vaccines market is now growing tremendously due to the growth in the number of pets being adopted globally and specifically cats and dogs. Due to the growing acceptance of pets as family members, the demand of preventive health care measures such as vaccination is on the steep. The market is reacting with superior, secure and efficient vaccination items to secure the long term health of the pets, enhance general wellbeing and to meet the changing needs of responsible owners of pets globally.

Research and development, manufacturing, quality test, and cold-chain logistics are very expensive in the development and delivery of pet vaccines. Such high costs lead to the high prices of vaccines which are prohibitive to pet owners in low-income areas. Therefore, the pet vaccines sector has the difficulty of gaining mass adoption and especially in the developing world where price is a key obstacle to preventive medication.

The increasing use of pet insurance and wellness programs including vaccinations is providing a huge potential in the pet vaccines industry. These programs make people more inclined to adhere to the recommended vaccination schedules, which raises the rates of vaccine uptake by making regular preventative care the incentive. The trend will enable manufacturers to increase their market reach, launch new products, and tap into the growing demand of some of the health-conscious pet owners to receive a complete preventive healthcare solution.

Expansion of Global Pet Vaccines Market

“Innovation that propel the global pet vaccines market expansion”

  • The pet vaccines market has been growing very fast with the driving forces being the increase in pet ownership, awareness of preventive care, and pet humanization. The owners of pets are increasingly focusing on routine immunizations in order to keep their pets healthy against infectious and zoonotic diseases, and new vaccine technologies, such as combination, recombinant, and next-generation technologies, are boosting the effectiveness and convenience.
  • The enhanced rates of adoption are further supported by strong veterinary recommendations, increasing the rate of pet insurance coverage, and increasing the distribution networks, which makes the market a dynamic and rapidly developing sector of the animal health industry.

Regional Analysis of Global Pet Vaccines Market

  • North America leads the pet vaccines market due to high pet ownership rates, strong awareness of preventive healthcare, and well-established veterinary infrastructure. Pet owners increasingly prioritize routine vaccinations for dogs and cats, supported by comprehensive veterinary guidance and updated immunization protocols. The region benefits from advanced distribution networks, favorable regulatory frameworks, and widespread pet insurance and wellness programs, which encourage consistent vaccine adoption. Additionally, continuous innovation in vaccine technologies and biologics further reinforces North America’s dominant position in the global pet vaccines market.
  • The Asia Pacific pet vaccines market is experiencing rapid growth, fueled by increasing pet ownership, rising disposable incomes, and growing awareness of preventive animal healthcare. Expanding urbanization and the humanization of pets are encouraging owners to invest in routine vaccinations. Additionally, the region is witnessing enhanced veterinary infrastructure, increased availability of advanced vaccine products, and growing penetration of international animal health companies, all of which are driving higher adoption rates and contributing to the robust expansion of the pet vaccines market across Asia Pacific.

Prominent players operating in the global pet vaccines market are Bimeda Holdings, Biovac, Boehringer Ingelheim Animal Health, Brilliant Bio Pharma, Ceva Santé Animale, ChengDu Tecbond Biological Products Co., Colorado Serum Company, Dechra Pharmaceuticals, Elanco Animal Health, Hester Biosciences Limited, IDT Biologika GmbH, Indian Immunologicals Limited, Laboratorios Hipra S.A., Merck Animal Health (MSD Animal Health), Neogen Corporation, Phibro Animal Health Corporation, Vaxxinova International, Vetoquinol, Virbac, Yebio Bioengineering Co., Zoetis Inc., Other Key Players.

The global pet vaccines market has been segmented as follows:

Global Pet Vaccines Market Analysis, By Animal Type

  • Dogs
    • Small breeds
    • Medium breeds
    • Large breeds
  • Cats
    • Indoor cats
    • Outdoor cats
  • Horses
  • Livestock
    • Cattle
    • Swine
    • Poultry
    • Others
  • Other companion animals
    • Rabbits
    • Ferrets
    • Guinea pigs

Global Pet Vaccines Market Analysis, By Vaccine Type

  • Attenuated (Live) Vaccines
  • Inactivated (Killed) Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Conjugate Vaccines

Global Pet Vaccines Market Analysis, By Disease Indication

  • Rabies
  • Distemper
  • Parvovirus
  • Adenovirus
  • Leptospirosis
  • Bordetella (Kennel Cough)
  • Feline Leukemia Virus (FeLV)
  • Feline Immunodeficiency Virus (FIV)
  • Canine Influenza
  • Lyme Disease
  • Feline Panleukopenia
  • Equine Influenza
  • West Nile Virus
  • Others

Global Pet Vaccines Market Analysis, By Route of Administration

  • Injectable
    • Intramuscular
    • Subcutaneous
    • Intradermal
  • Oral
  • Intranasal
  • Transdermal

Global Pet Vaccines Market Analysis, By Product Form

  • Liquid Vaccines
  • Freeze-dried (Lyophilized) Vaccines
  • Ready-to-use Formulations
  • Reconstitutable Formulations

Global Pet Vaccines Market Analysis, By Valency

  • Monovalent Vaccines
  • Multivalent (Combination) Vaccines
    • Bivalent
    • Trivalent
    • Tetravalent
    • Pentavalent and above

Global Pet Vaccines Market Analysis, By Age Group

  • Puppy/Kitten (Pediatric)
  • Adult
  • Geriatric/Senior
  • All age groups

Global Pet Vaccines Market Analysis, By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Pharmacies
  • Animal Shelters
  • Pet Specialty Stores
  • Others

Global Pet Vaccines Market Analysis, By Prescription Type

  • Prescription-based Vaccines
  • Over-the-counter (OTC) Vaccines
  • Veterinarian-administered Only

Global Pet Vaccines Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

​​About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Pet Vaccines Market Outlook
      • 2.1.1. Pet Vaccines Market Size Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising pet ownership and growing demand for preventive pet healthcare worldwide.
        • 4.1.1.2. Increasing prevalence of zoonotic and infectious diseases in companion animals, boosting vaccination adoption.
        • 4.1.1.3. Technological advancements and innovations in vaccine development improving efficacy and accessibility.
      • 4.1.2. Restraints
        • 4.1.2.1. High cost of vaccines and limited access to veterinary care, especially in lower‑income or rural regions.
        • 4.1.2.2. Vaccine hesitancy among pet owners due to safety concerns and lack of awareness.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Raw Material Suppliers
      • 4.4.2. Manufacturing & Production
      • 4.4.3. Distribution & Logistics
      • 4.4.4. Marketing & Sales
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Pet Vaccines Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Pet Vaccines Market Analysis, by Animal Type
    • 6.1. Key Segment Analysis
    • 6.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Animal Type, 2021-2035
      • 6.2.1. Dogs
        • 6.2.1.1. Small breeds
        • 6.2.1.2. Medium breeds
        • 6.2.1.3. Large breeds
      • 6.2.2. Cats
        • 6.2.2.1. Indoor cats
        • 6.2.2.2. Outdoor cats
      • 6.2.3. Horses
      • 6.2.4. Livestock
        • 6.2.4.1. Cattle
        • 6.2.4.2. Swine
        • 6.2.4.3. Poultry
        • 6.2.4.4. Others
      • 6.2.5. Other companion animals
        • 6.2.5.1. Rabbits
        • 6.2.5.2. Ferrets
        • 6.2.5.3. Guinea pigs
  • 7. Global Pet Vaccines Market Analysis, by Vaccine Type
    • 7.1. Key Segment Analysis
    • 7.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Vaccine Type, 2021-2035
      • 7.2.1. Attenuated (Live) Vaccines
      • 7.2.2. Inactivated (Killed) Vaccines
      • 7.2.3. Recombinant Vaccines
      • 7.2.4. Subunit Vaccines
      • 7.2.5. Toxoid Vaccines
      • 7.2.6. DNA Vaccines
      • 7.2.7. Conjugate Vaccines
  • 8. Global Pet Vaccines Market Analysis, by Disease Indication
    • 8.1. Key Segment Analysis
    • 8.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Disease Indication, 2021-2035
      • 8.2.1. Rabies
      • 8.2.2. Distemper
      • 8.2.3. Parvovirus
      • 8.2.4. Adenovirus
      • 8.2.5. Leptospirosis
      • 8.2.6. Bordetella (Kennel Cough)
      • 8.2.7. Feline Leukemia Virus (FeLV)
      • 8.2.8. Feline Immunodeficiency Virus (FIV)
      • 8.2.9. Canine Influenza
      • 8.2.10. Lyme Disease
      • 8.2.11. Feline Panleukopenia
      • 8.2.12. Equine Influenza
      • 8.2.13. West Nile Virus
      • 8.2.14. Others
  • 9. Global Pet Vaccines Market Analysis, by Route of Administration
    • 9.1. Key Segment Analysis
    • 9.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Route of Administration, 2021-2035
      • 9.2.1. Injectable
        • 9.2.1.1. Intramuscular
        • 9.2.1.2. Subcutaneous
        • 9.2.1.3. Intradermal
      • 9.2.2. Oral
      • 9.2.3. Intranasal
      • 9.2.4. Transdermal
  • 10. Global Pet Vaccines Market Analysis, by Product Form
    • 10.1. Key Segment Analysis
    • 10.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Product Form, 2021-2035
      • 10.2.1. Liquid Vaccines
      • 10.2.2. Freeze-dried (Lyophilized) Vaccines
      • 10.2.3. Ready-to-use Formulations
      • 10.2.4. Reconstitutable Formulations
  • 11. Global Pet Vaccines Market Analysis, by Valency
    • 11.1. Key Segment Analysis
    • 11.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Valency, 2021-2035
      • 11.2.1. Monovalent Vaccines
      • 11.2.2. Multivalent (Combination) Vaccines
        • 11.2.2.1. Bivalent
        • 11.2.2.2. Trivalent
        • 11.2.2.3. Tetravalent
        • 11.2.2.4. Pentavalent and above
  • 12. Global Pet Vaccines Market Analysis, by Age Group
    • 12.1. Key Segment Analysis
    • 12.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Age Group, 2021-2035
      • 12.2.1. Puppy/Kitten (Pediatric)
      • 12.2.2. Adult
      • 12.2.3. Geriatric/Senior
      • 12.2.4. All age groups
  • 13. Global Pet Vaccines Market Analysis and Forecasts, by Distribution Channel
    • 13.1. Key Findings
    • 13.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 13.2.1. Veterinary Hospitals
      • 13.2.2. Veterinary Clinics
      • 13.2.3. Veterinary Pharmacies
      • 13.2.4. Animal Shelters
      • 13.2.5. Pet Specialty Stores
      • 13.2.6. Others
  • 14. Global Pet Vaccines Market Analysis and Forecasts, by Prescription Type
    • 14.1. Key Findings
    • 14.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Prescription Type, 2021-2035
      • 14.2.1. Prescription-based Vaccines
      • 14.2.2. Over-the-counter (OTC) Vaccines
      • 14.2.3. Veterinarian-administered Only
  • 15. Global Pet Vaccines Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Pet Vaccines Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Animal Type
      • 16.3.2. Vaccine Type
      • 16.3.3. Disease Indication
      • 16.3.4. Route of Administration
      • 16.3.5. Product Form
      • 16.3.6. Valency
      • 16.3.7. Age Group
      • 16.3.8. Distribution Channel
      • 16.3.9. Prescription Type
      • 16.3.10. Country
        • 16.3.10.1. USA
        • 16.3.10.2. Canada
        • 16.3.10.3. Mexico
    • 16.4. USA Pet Vaccines Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Animal Type
      • 16.4.3. Vaccine Type
      • 16.4.4. Disease Indication
      • 16.4.5. Route of Administration
      • 16.4.6. Product Form
      • 16.4.7. Valency
      • 16.4.8. Age Group
      • 16.4.9. Distribution Channel
      • 16.4.10. Prescription Type
    • 16.5. Canada Pet Vaccines Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Animal Type
      • 16.5.3. Vaccine Type
      • 16.5.4. Disease Indication
      • 16.5.5. Route of Administration
      • 16.5.6. Product Form
      • 16.5.7. Valency
      • 16.5.8. Age Group
      • 16.5.9. Distribution Channel
      • 16.5.10. Prescription Type
    • 16.6. Mexico Pet Vaccines Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Animal Type
      • 16.6.3. Vaccine Type
      • 16.6.4. Disease Indication
      • 16.6.5. Route of Administration
      • 16.6.6. Product Form
      • 16.6.7. Valency
      • 16.6.8. Age Group
      • 16.6.9. Distribution Channel
      • 16.6.10. Prescription Type
  • 17. Europe Pet Vaccines Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Monitoring Type
      • 17.3.2. Animal Type
      • 17.3.3. Vaccine Type
      • 17.3.4. Disease Indication
      • 17.3.5. Route of Administration
      • 17.3.6. Product Form
      • 17.3.7. Valency
      • 17.3.8. Age Group
      • 17.3.9. Distribution Channel
      • 17.3.10. Prescription Type
      • 17.3.11. Country
        • 17.3.11.1. Germany
        • 17.3.11.2. United Kingdom
        • 17.3.11.3. France
        • 17.3.11.4. Italy
        • 17.3.11.5. Spain
        • 17.3.11.6. Netherlands
        • 17.3.11.7. Nordic Countries
        • 17.3.11.8. Poland
        • 17.3.11.9. Russia & CIS
        • 17.3.11.10. Rest of Europe
    • 17.4. Germany Pet Vaccines Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Animal Type
      • 17.4.3. Vaccine Type
      • 17.4.4. Disease Indication
      • 17.4.5. Route of Administration
      • 17.4.6. Product Form
      • 17.4.7. Valency
      • 17.4.8. Age Group
      • 17.4.9. Distribution Channel
      • 17.4.10. Prescription Type
    • 17.5. United Kingdom Pet Vaccines Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Animal Type
      • 17.5.3. Vaccine Type
      • 17.5.4. Disease Indication
      • 17.5.5. Route of Administration
      • 17.5.6. Product Form
      • 17.5.7. Valency
      • 17.5.8. Age Group
      • 17.5.9. Distribution Channel
      • 17.5.10. Prescription Type
    • 17.6. France Pet Vaccines Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Animal Type
      • 17.6.3. Vaccine Type
      • 17.6.4. Disease Indication
      • 17.6.5. Route of Administration
      • 17.6.6. Product Form
      • 17.6.7. Valency
      • 17.6.8. Age Group
      • 17.6.9. Distribution Channel
      • 17.6.10. Prescription Type
    • 17.7. Italy Pet Vaccines Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Animal Type
      • 17.7.3. Vaccine Type
      • 17.7.4. Disease Indication
      • 17.7.5. Route of Administration
      • 17.7.6. Product Form
      • 17.7.7. Valency
      • 17.7.8. Age Group
      • 17.7.9. Distribution Channel
      • 17.7.10. Prescription Type
    • 17.8. Spain Pet Vaccines Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Animal Type
      • 17.8.3. Vaccine Type
      • 17.8.4. Disease Indication
      • 17.8.5. Route of Administration
      • 17.8.6. Product Form
      • 17.8.7. Valency
      • 17.8.8. Age Group
      • 17.8.9. Distribution Channel
      • 17.8.10. Prescription Type
    • 17.9. Netherlands Pet Vaccines Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Animal Type
      • 17.9.3. Vaccine Type
      • 17.9.4. Disease Indication
      • 17.9.5. Route of Administration
      • 17.9.6. Product Form
      • 17.9.7. Valency
      • 17.9.8. Age Group
      • 17.9.9. Distribution Channel
      • 17.9.10. Prescription Type
    • 17.10. Nordic Countries Pet Vaccines Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Animal Type
      • 17.10.3. Vaccine Type
      • 17.10.4. Disease Indication
      • 17.10.5. Route of Administration
      • 17.10.6. Product Form
      • 17.10.7. Valency
      • 17.10.8. Age Group
      • 17.10.9. Distribution Channel
      • 17.10.10. Prescription Type
    • 17.11. Poland Pet Vaccines Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Animal Type
      • 17.11.3. Vaccine Type
      • 17.11.4. Disease Indication
      • 17.11.5. Route of Administration
      • 17.11.6. Product Form
      • 17.11.7. Valency
      • 17.11.8. Age Group
      • 17.11.9. Distribution Channel
      • 17.11.10. Prescription Type
      • 17.11.11. End-use Industry
    • 17.12. Russia & CIS Pet Vaccines Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Animal Type
      • 17.12.3. Vaccine Type
      • 17.12.4. Disease Indication
      • 17.12.5. Route of Administration
      • 17.12.6. Product Form
      • 17.12.7. Valency
      • 17.12.8. Age Group
      • 17.12.9. Distribution Channel
      • 17.12.10. Prescription Type
    • 17.13. Rest of Europe Pet Vaccines Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Animal Type
      • 17.13.3. Vaccine Type
      • 17.13.4. Disease Indication
      • 17.13.5. Route of Administration
      • 17.13.6. Product Form
      • 17.13.7. Valency
      • 17.13.8. Age Group
      • 17.13.9. Distribution Channel
      • 17.13.10. Prescription Type
  • 18. Asia Pacific Pet Vaccines Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Animal Type
      • 18.3.2. Vaccine Type
      • 18.3.3. Disease Indication
      • 18.3.4. Route of Administration
      • 18.3.5. Product Form
      • 18.3.6. Valency
      • 18.3.7. Age Group
      • 18.3.8. Distribution Channel
      • 18.3.9. Prescription Type
      • 18.3.10. Country
        • 18.3.10.1. China
        • 18.3.10.2. India
        • 18.3.10.3. Japan
        • 18.3.10.4. South Korea
        • 18.3.10.5. Australia and New Zealand
        • 18.3.10.6. Indonesia
        • 18.3.10.7. Malaysia
        • 18.3.10.8. Thailand
        • 18.3.10.9. Vietnam
        • 18.3.10.10. Rest of Asia Pacific
    • 18.4. China Pet Vaccines Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Animal Type
      • 18.4.3. Vaccine Type
      • 18.4.4. Disease Indication
      • 18.4.5. Route of Administration
      • 18.4.6. Product Form
      • 18.4.7. Valency
      • 18.4.8. Age Group
      • 18.4.9. Distribution Channel
      • 18.4.10. Prescription Type
    • 18.5. India Pet Vaccines Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Animal Type
      • 18.5.3. Vaccine Type
      • 18.5.4. Disease Indication
      • 18.5.5. Route of Administration
      • 18.5.6. Product Form
      • 18.5.7. Valency
      • 18.5.8. Age Group
      • 18.5.9. Distribution Channel
      • 18.5.10. Prescription Type
    • 18.6. Japan Pet Vaccines Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Animal Type
      • 18.6.3. Vaccine Type
      • 18.6.4. Disease Indication
      • 18.6.5. Route of Administration
      • 18.6.6. Product Form
      • 18.6.7. Valency
      • 18.6.8. Age Group
      • 18.6.9. Distribution Channel
      • 18.6.10. Prescription Type
    • 18.7. South Korea Pet Vaccines Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Animal Type
      • 18.7.3. Vaccine Type
      • 18.7.4. Disease Indication
      • 18.7.5. Route of Administration
      • 18.7.6. Product Form
      • 18.7.7. Valency
      • 18.7.8. Age Group
      • 18.7.9. Distribution Channel
      • 18.7.10. Prescription Type
    • 18.8. Australia and New Zealand Pet Vaccines Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Animal Type
      • 18.8.3. Vaccine Type
      • 18.8.4. Disease Indication
      • 18.8.5. Route of Administration
      • 18.8.6. Product Form
      • 18.8.7. Valency
      • 18.8.8. Age Group
      • 18.8.9. Distribution Channel
      • 18.8.10. Prescription Type
    • 18.9. Indonesia Pet Vaccines Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Animal Type
      • 18.9.3. Vaccine Type
      • 18.9.4. Disease Indication
      • 18.9.5. Route of Administration
      • 18.9.6. Product Form
      • 18.9.7. Valency
      • 18.9.8. Age Group
      • 18.9.9. Distribution Channel
      • 18.9.10. Prescription Type
    • 18.10. Malaysia Pet Vaccines Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Animal Type
      • 18.10.3. Vaccine Type
      • 18.10.4. Disease Indication
      • 18.10.5. Route of Administration
      • 18.10.6. Product Form
      • 18.10.7. Valency
      • 18.10.8. Age Group
      • 18.10.9. Distribution Channel
      • 18.10.10. Prescription Type
    • 18.11. Thailand Pet Vaccines Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Animal Type
      • 18.11.3. Vaccine Type
      • 18.11.4. Disease Indication
      • 18.11.5. Route of Administration
      • 18.11.6. Product Form
      • 18.11.7. Valency
      • 18.11.8. Age Group
      • 18.11.9. Distribution Channel
      • 18.11.10. Prescription Type
    • 18.12. Vietnam Pet Vaccines Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Animal Type
      • 18.12.3. Vaccine Type
      • 18.12.4. Disease Indication
      • 18.12.5. Route of Administration
      • 18.12.6. Product Form
      • 18.12.7. Valency
      • 18.12.8. Age Group
      • 18.12.9. Distribution Channel
      • 18.12.10. Prescription Type
    • 18.13. Rest of Asia Pacific Pet Vaccines Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Animal Type
      • 18.13.3. Vaccine Type
      • 18.13.4. Disease Indication
      • 18.13.5. Route of Administration
      • 18.13.6. Product Form
      • 18.13.7. Valency
      • 18.13.8. Age Group
      • 18.13.9. Distribution Channel
      • 18.13.10. Prescription Type
  • 19. Middle East Pet Vaccines Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Animal Type
      • 19.3.2. Vaccine Type
      • 19.3.3. Disease Indication
      • 19.3.4. Route of Administration
      • 19.3.5. Product Form
      • 19.3.6. Valency
      • 19.3.7. Age Group
      • 19.3.8. Distribution Channel
      • 19.3.9. Prescription Type
      • 19.3.10. Country
        • 19.3.10.1. Turkey
        • 19.3.10.2. UAE
        • 19.3.10.3. Saudi Arabia
        • 19.3.10.4. Israel
        • 19.3.10.5. Rest of Middle East
    • 19.4. Turkey Pet Vaccines Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Animal Type
      • 19.4.3. Vaccine Type
      • 19.4.4. Disease Indication
      • 19.4.5. Route of Administration
      • 19.4.6. Product Form
      • 19.4.7. Valency
      • 19.4.8. Age Group
      • 19.4.9. Distribution Channel
      • 19.4.10. Prescription Type
    • 19.5. UAE Pet Vaccines Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Animal Type
      • 19.5.3. Vaccine Type
      • 19.5.4. Disease Indication
      • 19.5.5. Route of Administration
      • 19.5.6. Product Form
      • 19.5.7. Valency
      • 19.5.8. Age Group
      • 19.5.9. Distribution Channel
      • 19.5.10. Prescription Type
    • 19.6. Saudi Arabia Pet Vaccines Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Animal Type
      • 19.6.3. Vaccine Type
      • 19.6.4. Disease Indication
      • 19.6.5. Route of Administration
      • 19.6.6. Product Form
      • 19.6.7. Valency
      • 19.6.8. Age Group
      • 19.6.9. Distribution Channel
      • 19.6.10. Prescription Type
    • 19.7. Israel Pet Vaccines Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Animal Type
      • 19.7.3. Vaccine Type
      • 19.7.4. Disease Indication
      • 19.7.5. Route of Administration
      • 19.7.6. Product Form
      • 19.7.7. Valency
      • 19.7.8. Age Group
      • 19.7.9. Distribution Channel
      • 19.7.10. Prescription Type
    • 19.8. Rest of Middle East Pet Vaccines Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Animal Type
      • 19.8.3. Vaccine Type
      • 19.8.4. Disease Indication
      • 19.8.5. Route of Administration
      • 19.8.6. Product Form
      • 19.8.7. Valency
      • 19.8.8. Age Group
      • 19.8.9. Distribution Channel
      • 19.8.10. Prescription Type
  • 20. Africa Pet Vaccines Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Animal Type
      • 20.3.2. Vaccine Type
      • 20.3.3. Disease Indication
      • 20.3.4. Route of Administration
      • 20.3.5. Product Form
      • 20.3.6. Valency
      • 20.3.7. Age Group
      • 20.3.8. Distribution Channel
      • 20.3.9. Prescription Type
      • 20.3.10. Country
        • 20.3.10.1. South Africa
        • 20.3.10.2. Egypt
        • 20.3.10.3. Nigeria
        • 20.3.10.4. Algeria
        • 20.3.10.5. Rest of Africa
    • 20.4. South Africa Pet Vaccines Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Animal Type
      • 20.4.3. Vaccine Type
      • 20.4.4. Disease Indication
      • 20.4.5. Route of Administration
      • 20.4.6. Product Form
      • 20.4.7. Valency
      • 20.4.8. Age Group
      • 20.4.9. Distribution Channel
      • 20.4.10. Prescription Type
    • 20.5. Egypt Pet Vaccines Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Animal Type
      • 20.5.3. Vaccine Type
      • 20.5.4. Disease Indication
      • 20.5.5. Route of Administration
      • 20.5.6. Product Form
      • 20.5.7. Valency
      • 20.5.8. Age Group
      • 20.5.9. Distribution Channel
      • 20.5.10. Prescription Type
    • 20.6. Nigeria Pet Vaccines Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Animal Type
      • 20.6.3. Vaccine Type
      • 20.6.4. Disease Indication
      • 20.6.5. Route of Administration
      • 20.6.6. Product Form
      • 20.6.7. Valency
      • 20.6.8. Age Group
      • 20.6.9. Distribution Channel
      • 20.6.10. Prescription Type
    • 20.7. Algeria Pet Vaccines Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Animal Type
      • 20.7.3. Vaccine Type
      • 20.7.4. Disease Indication
      • 20.7.5. Route of Administration
      • 20.7.6. Product Form
      • 20.7.7. Valency
      • 20.7.8. Age Group
      • 20.7.9. Distribution Channel
      • 20.7.10. Prescription Type
    • 20.8. Rest of Africa Pet Vaccines Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Animal Type
      • 20.8.3. Vaccine Type
      • 20.8.4. Disease Indication
      • 20.8.5. Route of Administration
      • 20.8.6. Product Form
      • 20.8.7. Valency
      • 20.8.8. Age Group
      • 20.8.9. Distribution Channel
      • 20.8.10. Prescription Type
  • 21. South America Pet Vaccines Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Pet Vaccines Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Animal Type
      • 21.3.2. Vaccine Type
      • 21.3.3. Disease Indication
      • 21.3.4. Route of Administration
      • 21.3.5. Product Form
      • 21.3.6. Valency
      • 21.3.7. Age Group
      • 21.3.8. Distribution Channel
      • 21.3.9. Prescription Type
      • 21.3.10. Country
        • 21.3.10.1. Brazil
        • 21.3.10.2. Argentina
        • 21.3.10.3. Rest of South America
    • 21.4. Brazil Pet Vaccines Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Animal Type
      • 21.4.3. Vaccine Type
      • 21.4.4. Disease Indication
      • 21.4.5. Route of Administration
      • 21.4.6. Product Form
      • 21.4.7. Valency
      • 21.4.8. Age Group
      • 21.4.9. Distribution Channel
      • 21.4.10. Prescription Type
    • 21.5. Argentina Pet Vaccines Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Animal Type
      • 21.5.3. Vaccine Type
      • 21.5.4. Disease Indication
      • 21.5.5. Route of Administration
      • 21.5.6. Product Form
      • 21.5.7. Valency
      • 21.5.8. Age Group
      • 21.5.9. Distribution Channel
      • 21.5.10. Prescription Type
    • 21.6. Rest of South America Pet Vaccines Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Animal Type
      • 21.6.3. Vaccine Type
      • 21.6.4. Disease Indication
      • 21.6.5. Route of Administration
      • 21.6.6. Product Form
      • 21.6.7. Valency
      • 21.6.8. Age Group
      • 21.6.9. Distribution Channel
      • 21.6.10. Prescription Type
  • 22. Key Players/ Company Profile
    • 22.1. Bimeda Holdings
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. Biovac
    • 22.3. Boehringer Ingelheim Animal Health
    • 22.4. Brilliant Bio Pharma
    • 22.5. Ceva Santé Animale
    • 22.6. ChengDu Tecbond Biological Products Co.
    • 22.7. Colorado Serum Company
    • 22.8. Dechra Pharmaceuticals
    • 22.9. Elanco Animal Health
    • 22.10. Hester Biosciences Limited
    • 22.11. IDT Biologika GmbH
    • 22.12. Indian Immunologicals Limited
    • 22.13. Laboratorios Hipra S.A.
    • 22.14. Merck Animal Health (MSD Animal Health)
    • 22.15. Neogen Corporation
    • 22.16. Phibro Animal Health Corporation
    • 22.17. Vaxxinova International
    • 22.18. Vetoquinol
    • 22.19. Virbac
    • 22.20. Yebio Bioengineering Co.
    • 22.21. Zoetis Inc.
    • 22.22. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation